Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
0.39
0.02 (5.89%)
At close: Jun 06, 2025, 3:59 PM
0.38
-2.70%
After-hours: Jun 06, 2025, 05:17 PM EDT

Mersana Therapeutics Statistics

Share Statistics

Mersana Therapeutics has 124.63M shares outstanding. The number of shares has increased by 1.86% in one year.

124.63M
1.86%
0.89%
84.99%
n/a
5,812
0.2%

Short Selling Information

The latest short interest is 12.78M, so 10.26% of the outstanding shares have been sold short.

12.78M
10.26%
11.2%
5.6

Valuation Ratios

The PE ratio is -2.53 and the forward PE ratio is -0.62. Mersana Therapeutics's PEG ratio is 0.04.

-2.53
-0.62
4.33
0.1
-18.43
-2.12
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Mersana Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of -3.01.

2.19
2.19
-3.01
-0.45
-0.35
-18.93

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$397,029.41
$-678,352.94
102
0.28
n/a

Taxes

418K
-0.61%

Stock Price Statistics

The stock price has increased by -83.78% in the last 52 weeks. The beta is 0.82, so Mersana Therapeutics's price volatility has been higher than the market average.

0.82
-83.78%
0.35
1.18
50.9
2,857,385

Income Statement

In the last 12 months, Mersana Therapeutics had revenue of 40.5M and earned -69.19M in profits. Earnings per share was -0.56.

40.5M
40.5M
-73.34M
-69.19M
-63.27M
-64.9M
-0.56
Full Income Statement

Balance Sheet

The company has 107.75M in cash and 28.6M in debt, giving a net cash position of 79.15M.

107.75M
28.6M
79.15M
-895.55M
112.47M
48.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -82.34M and capital expenditures -132K, giving a free cash flow of -82.47M.

-82.34M
-132K
-82.47M
-0.67
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -181.09% and -170.86%.

100%
-181.09%
-169.82%
-170.86%
-156.24%
-181.09%
-203.65%

Dividends & Yields

MRSN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MRSN is $5, which is 1288.9% higher than the current price. The consensus rating is "Buy".

$5
1288.9%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-12.5
2